Healthcare provider profile · identity verified

Sammy Hamid, M.D.

Internal Medicine · PHILADELPHIA, PA · NPI 1225077985

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	656	193
Amlodipine Besylate	Amlodipine Besylate	398	103
Eliquis	Apixaban	369	69
Furosemide	Furosemide	284	67
Gabapentin	Gabapentin	279	86
Pantoprazole Sodium	Pantoprazole Sodium	279	73
Carvedilol	Carvedilol	201	49
Metoprolol Succinate	Metoprolol Succinate	201	65
Mirtazapine	Mirtazapine	188	40
Losartan Potassium	Losartan Potassium	158	52
Levothyroxine Sodium	Levothyroxine Sodium	150	47
Potassium Chloride	Potassium Chloride	138	42
Trazodone Hcl	Trazodone Hcl	137	29
Omeprazole	Omeprazole	127	50
Tamsulosin Hcl	Tamsulosin Hcl	124	54
Duloxetine Hcl	Duloxetine Hcl	122	32
Nystatin	Nystatin	116	17
Lisinopril	Lisinopril	111	41
Metformin Hcl	Metformin Hcl	110	32
Sertraline Hcl	Sertraline Hcl	105	33
Entresto	Sacubitril/Valsartan	104	15
Xarelto	Rivaroxaban	104	14
Escitalopram Oxalate	Escitalopram Oxalate	100	27
Donepezil Hcl	Donepezil Hcl	92	20
Clopidogrel	Clopidogrel Bisulfate	91	29
Famotidine	Famotidine	87	35
Levetiracetam	Levetiracetam	72	23
Pregabalin	Pregabalin	69	suppressed
Hydralazine Hcl	Hydralazine Hcl	68	19
Metoprolol Tartrate	Metoprolol Tartrate	67	27
Olanzapine	Olanzapine	67	suppressed
Amiodarone Hcl	Amiodarone Hcl	64	20
Prednisone	Prednisone	62	20
Nifedipine Er	Nifedipine	60	19
Spironolactone	Spironolactone	60	18
Metolazone	Metolazone	58	suppressed
Buspirone Hcl	Buspirone Hcl	55	suppressed
Divalproex Sodium	Divalproex Sodium	55	suppressed
Jardiance	Empagliflozin	54	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	17
Torsemide	Torsemide	54	17
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	52	23
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	25
Naproxen	Naproxen	51	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	49	suppressed
Fluticasone Propionate	Fluticasone Propionate	47	19
Lacosamide	Lacosamide	47	suppressed
Bumetanide	Bumetanide	45	15
Allopurinol	Allopurinol	42	19
Finasteride	Finasteride	42	15
Oxycodone Hcl	Oxycodone Hcl	41	22
Anastrozole	Anastrozole	40	suppressed
Aripiprazole	Aripiprazole	40	13
Carbidopa-Levodopa	Carbidopa/Levodopa	38	13
Midodrine Hcl	Midodrine Hcl	38	suppressed
Alogliptin	Alogliptin Benzoate	37	12
Benztropine Mesylate	Benztropine Mesylate	37	suppressed
Simvastatin	Simvastatin	37	13
Fluoxetine Hcl	Fluoxetine Hcl	36	suppressed
Austedo	Deutetrabenazine	35	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Farxiga	Dapagliflozin Propanediol	35	suppressed
Lorazepam	Lorazepam	35	14
Oxybutynin Chloride Er	Oxybutynin Chloride	35	12
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	35	suppressed
Incruse Ellipta	Umeclidinium Bromide	33	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	32	14
Risperidone	Risperidone	32	suppressed
Clonazepam	Clonazepam	31	suppressed
Lokelma	Sodium Zirconium Cyclosilicate	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	19
Albuterol Sulfate Hfa	Albuterol Sulfate	30	21
Baclofen	Baclofen	30	suppressed
Glipizide	Glipizide	30	suppressed
Montelukast Sodium	Montelukast Sodium	30	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	29	12
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	28	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	28	suppressed
Glipizide Er	Glipizide	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Levofloxacin	Levofloxacin	27	12
Bupropion Xl	Bupropion Hcl	26	suppressed
Permethrin	Permethrin	26	12
Trintellix	Vortioxetine Hydrobromide	26	suppressed
Ezetimibe	Ezetimibe	25	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	25	12
Insulin Lispro	Insulin Lispro	25	suppressed
Ondansetron Hcl	Ondansetron Hcl	25	20
Metformin Hcl Er	Metformin Hcl	24	12
Triamcinolone Acetonide	Triamcinolone Acetonide	23	12
Atenolol	Atenolol	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	12
Latanoprost	Latanoprost	22	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	21	suppressed
Vascepa	Icosapent Ethyl	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Alendronate Sodium	Alendronate Sodium	19	suppressed
Digoxin	Digoxin	19	suppressed
Fenofibrate	Fenofibrate	19	suppressed
Memantine Hcl	Memantine Hcl	19	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	19	suppressed
Theophylline Er	Theophylline Anhydrous	19	suppressed
Albuterol Sulfate	Albuterol Sulfate	18	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Ibuprofen	Ibuprofen	18	11
Lovastatin	Lovastatin	18	suppressed
Humalog Kwikpen U-100	Insulin Lispro	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Diltiazem 24hr Er (La)	Diltiazem Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Lactulose	Lactulose	16	suppressed
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Valproic Acid	Valproic Acid (As Sodium Salt)	16	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	15	15
Cholestyramine	Cholestyramine (With Sugar)	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Lurasidone Hcl	Lurasidone Hcl	15	suppressed
Tivicay	Dolutegravir Sodium	15	suppressed
Valsartan	Valsartan	15	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	suppressed
Primidone	Primidone	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Alprazolam	Alprazolam	13	suppressed
Betamethasone Valerate	Betamethasone Valerate	13	suppressed
Dofetilide	Dofetilide	13	suppressed
Fluphenazine Hcl	Fluphenazine Hcl	13	suppressed
Humalog Mix 75-25	Insulin Lispro Protamin/Lispro	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Nystop	Nystatin	13	suppressed
Sevelamer Carbonate	Sevelamer Carbonate	13	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	13	suppressed
Carbamazepine	Carbamazepine	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Clobazam	Clobazam	12	suppressed
Desipramine Hcl	Desipramine Hcl	12	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	12	suppressed
Repaglinide	Repaglinide	12	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	12	suppressed
Sodium Chloride	0.9 % Sodium Chloride	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Haloperidol	Haloperidol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	11	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	11	suppressed
Ozempic	Semaglutide	11	suppressed
Prednisolone Acetate	Prednisolone Acetate	11	suppressed
Tetrabenazine	Tetrabenazine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error